Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss
Seamless Therapeutics -- Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise...
